EODData

NSE, NGLFINE: NGL Fine-Chem Limited

24 Nov 2025
LAST:

1,321

CHANGE:
 26.90
OPEN:
1,333
HIGH:
1,347
ASK:
0
VOLUME:
2.0K
CHG(%):
2.00
PREV:
1,348
LOW:
1,295
BID:
0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Nov 251,3331,3471,2951,3212.0K
21 Nov 251,3821,4121,3151,3483.8K
20 Nov 251,3681,4081,3581,3923.4K
19 Nov 251,3821,4141,3451,3562.4K
18 Nov 251,3701,4031,3111,3935.1K
17 Nov 251,3921,3921,3381,3613.1K
14 Nov 251,4501,4501,3821,3904.0K
13 Nov 251,4651,4651,4061,4262.1K
12 Nov 251,4591,4831,4401,4432.8K
11 Nov 251,4661,4891,4451,4495.7K

PROFILE

Name:NGL Fine-Chem Limited
About:NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Sector:Healthcare
Address:301, E Square, Mumbai, India, 400057
Website:https://www.nglfinechem.com
ISIN:INE887E01022

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:44.87 
PEG Ratio:167.38 
Price to Sales:2.49 
Price to Book:3.37 
Profit Margin:0.06 
Operating Margin:0.06 
Return on Assets:0.05 
Return on Equity:0.07 
Revenue:3.817B 
EBITDA:445.92M 
Shares:6.18M 
Market Cap:8.162B 

TECHNICAL INDICATORS

MA5:1,361.983.1%
MA10:1,387.815.0%
MA20:1,453.3410.0%
MA50:1,456.1610.2%
MA100:1,396.565.7%
MA200:1,254.375.3%
RSI14:31.45 
WPR14:-100.00 
MTM14:-308.90
ROC14:-0.19 
ATR:77.23 
Week High:1,413.907.0%
Week Low:1,294.702.0%
Month High:1,650.0024.9%
Month Low:1,294.705.3%
Year High:2,077.4557.3%
Year Low:957.0038.0%
Volatility:35.53 

RECENT DIVIDENDS

Date Amount
12 Aug 2025$1.75
16 Aug 2024$1.75
18 Aug 2023$1.75